Author:
Meinig Richard,Jarvis Stephanie,Salottolo Kristin,Nwafo Nnamdi,McNair Patrick,Harrison Paul,Morgan Steven,Duane Therese,Woods Bradley,Nentwig Michelle,Kelly Michael,Cornutt David,Bar-Or David
Abstract
Abstract
Background
Reversal of direct oral anticoagulants (DOACs) is currently recommended prior to emergent surgery, such as surgical intervention for traumatic geriatric hip fractures. However, reversal methods are expensive and timely, often delaying surgical intervention, which is a predictor of outcomes. The study objective was to examine the effect of DOAC reversal on blood loss and transfusions among geriatric patients with hip fractures.
Methods
This retrospective propensity-matched study across six level I trauma centers included geriatric patients on DOACs with isolated fragility hip fractures requiring surgical intervention (2014–2017). Outcomes included: intraoperative blood loss, intraoperative pRBCs, and hospital length of stay (HLOS).
Results
After matching there were 62 patients (31 reversed, 31 not reversed), 29 patients were not matched. The only reversal method utilized was passive reversal (waiting ≥ 24 hours for elimination). Passively reversed patients had a longer time to surgery (mean, 43 vs. 18 hours, p < 0.01). Most patients (92%) had blood loss (90% passively reversed, 94% not reversed); the median volume of blood loss was 100 mL for both those groups, p = 0.97. Thirteen percent had pRBCs transfused (13% passively reversed and 13% not reversed); the median volume of pRBCs transfused was 525 mL for those passively reversed and 314 mL for those not reversed, p = 0.52. The mean HLOS was significantly longer for those passively reversed (7 vs. 5 days, p = 0.001).
Conclusions
Passive DOAC reversal for geriatric patients with isolated hip fracture requiring surgery may be contributing to delayed surgery and an increased HLOS without having a significant effect on blood loss or transfusions. These data suggest that passive DOAC reversal may not be necessary prior to surgical repair of isolated hip fracture.
Publisher
Springer Science and Business Media LLC
Reference45 articles.
1. Yee J, Kaide CG. Emergency reversal of anticoagulation. Western J Emerg Med. 2019;20:770–83.
2. Barnes GD, Luxas E, Alexander GC, Goldberger ZD. National trends in ambulatory oral anticoagulant use. Am J Med. 2016;128:1300–5.
3. Aronis KN, Hylek EM. Who, when, and how to reverse non-vitamin K oral anticoagulants. J Thromb Thromb. 2016;41:253–72.
4. Brown KS, Zahir H, Grosso MA, Lanz HJ, Mercuri MF, Levy JH. Nonvitamin K antagonist oral anticoagulant activity: challenges in measurement and reversal. Crit Care Crit Care. 2016;20:1–10.
5. Riley TR, Gauthier-Lewis ML, Sanchez CK, Douglas JS. Role of agents for reversing the effects of target-specific oral anticoagulants. Am J Health Syst Pharm. 2017;74:54–61.